{"organizations": [], "uuid": "d86570927f0f95825ea0bb78659602df6ac99af5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?d=20180409&i=OV8APJFYJ&w=1200&r=OV8APJFYJ&t=2", "site_section": "http://feeds.reuters.com/reuters/USVideoLatest", "section_title": "Reuters Video: Latest Videos US", "url": "https://www.reuters.com/video/2018/04/09/novartis-to-buy-avexis-in-87bn-gene-ther?videoId=416242967", "country": "US", "domain_rank": 408, "title": "Novartis to buy AveXis in $8.7bn gene-therapy deal", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-09T15:45:00.000+03:00", "replies_count": 0, "uuid": "d86570927f0f95825ea0bb78659602df6ac99af5"}, "author": "", "url": "https://www.reuters.com/video/2018/04/09/novartis-to-buy-avexis-in-87bn-gene-ther?videoId=416242967", "ord_in_thread": 0, "title": "Novartis to buy AveXis in $8.7bn gene-therapy deal", "locations": [], "entities": {"persons": [{"name": "kate king", "sentiment": "none"}], "locations": [], "organizations": [{"name": "novartis", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Novartis to buy AveXis in $8.7bn gene-therapy deal 8:45am EDT - 01:28 \nSwiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.   \nSwiss drugmaker Novartis is moving further into gene therapy by buying AveXis for $8.7 billion, adding a rare-disease treatment that could reap billions in sales. Kate King reports.  //reut.rs/2JwayD5", "external_links": [], "published": "2018-04-09T15:45:00.000+03:00", "crawled": "2018-04-09T16:22:54.019+03:00", "highlightTitle": ""}